Talk to your provider about managing side effects rather than discontinuing treatment
The key difference is the receptor model
While real-world results may be slightly less, the improvements go beyond weight: Lower blood sugar, blood pressure, and triglycerides Reduced waist circumference and sleep apnea symptoms Better health-related quality of life Fewer major cardiovascular events Reduced progression of fatty liver disease and chronic kidney diseaseeven in the absence of weight loss (Mozaffarian et al., 2025)
Linked with metabolic regulation and nutrient processing
A retrospective cohort study using the TriNetX dataset revealed a significant correlation between GLP-1 RAs use and elevated aspiration pneumonia risk in patients undergoing gastrointestinal endoscopy, particularly among those receiving propofol sedation [20]
Many patients describe feeling more in control of their eating habits, leading to gradual, sustainable weight reduction